Yahoo
OTC Markets OTCPK USD

Shanrong Biotechnology Corp. (SRBT)

0.0001 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for SRBT
  • Previous Close 0.0001
  • Open 0.1000
  • Bid 0.0500 x 663700
  • Ask 0.1899 x 410000
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0001 - 0.2241
  • Volume 6,600
  • Avg. Volume 0
  • Market Cap (intraday) 100,048
  • Beta (5Y Monthly) 4.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Shanrong Biotechnology Corp. does not have significant operations. Previously, it was operated as a project management and executive consulting company. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Torrance, California.

--

Full Time Employees

December 31

Fiscal Year Ends

Shell Companies

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SRBT
99.90%
S&P 500 (^GSPC)
10.73%

1-Year Return

SRBT
99.94%
S&P 500 (^GSPC)
11.11%

3-Year Return

SRBT
99.97%
S&P 500 (^GSPC)
81.91%

5-Year Return

SRBT
99.99%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.07k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.87k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: